Cardiovascular Risk Clinical Trial
— ALLChangeOfficial title:
Changing Lifestyle in Children: All Change: Can This Reduce Cardiovascular Risk?
Verified date | January 2016 |
Source | University of Dundee |
Contact | n/a |
Is FDA regulated | No |
Health authority | United Kingdom: Research Ethics Committee |
Study type | Interventional |
A lifestyle intervention aimed at improving exercise levels in primary school children.
Status | Completed |
Enrollment | 92 |
Est. completion date | July 2007 |
Est. primary completion date | July 2007 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 9 Years to 11 Years |
Eligibility |
Inclusion Criteria - Children 9-11 yrs Exclusion Criteria: - Children <9 yrs and >12 yrs |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Dundee | University of St Andrews |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Can an acceptable strategy, based on social cultural factors that influence adherence to the strategy and designed for altering lifestyle associated with CV risk (ALL CHANGE) be developed for school aged children? | No | ||
Secondary | Is ALL CHANGE more effective in altering lifestyle than conventional health education delivered as part of the school curriculum? | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01139827 -
Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography
|
N/A | |
Recruiting |
NCT05767073 -
LIVES: Personalized Lifestyle Intervention for Patients With Depression
|
N/A | |
Completed |
NCT04626505 -
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
|
Phase 2 | |
Completed |
NCT00856882 -
The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors
|
N/A | |
Completed |
NCT04330937 -
Clinical Trial on the Effectiveness of Citrolive
|
N/A | |
Completed |
NCT01781416 -
Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk
|
N/A | |
Completed |
NCT01475513 -
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
|
Phase 4 | |
Enrolling by invitation |
NCT06122961 -
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
|
||
Completed |
NCT04506749 -
To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects
|
N/A | |
Completed |
NCT03412175 -
CREATION Health Lifestyle Intervention
|
N/A | |
Completed |
NCT02144922 -
Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients
|
Phase 4 | |
Completed |
NCT00921752 -
C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)
|
N/A | |
Completed |
NCT00697580 -
Strength and Nutrition Outcomes for Latino Adolescents
|
N/A | |
Enrolling by invitation |
NCT04450914 -
Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)
|
N/A | |
Completed |
NCT01003574 -
Evaluation of Cardiovascular Health Outcomes Among Survivors
|
N/A | |
Not yet recruiting |
NCT06118281 -
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
|
Phase 3 | |
Completed |
NCT01441323 -
Strength Training and Nutrition Development for African American Youth
|
N/A | |
Completed |
NCT01103648 -
Effect of Simvastatin and Ezetimibe on Lipid and Inflammation
|
N/A | |
Completed |
NCT01015092 -
Cardiovascular Risk Evaluation and Antiretrovirals in HIV
|
N/A | |
Not yet recruiting |
NCT05882266 -
The Role of Plant-Based Omega-3 Fatty Acids and Molecular Characterisation in Individuals With Cardiovascular(CVD) Risk
|
N/A |